GGrantIndex
← Leaderboards

Richard I Sherwood

Brigham And Women'S Hospital

$8,310,640
Attributed
$15,122,592
Total exposure
7
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3.4M · FY201425
$5M$3.8M$2.5M$1.3M$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$15,122,592 · 7

By mechanism

UM1$8,671,281 · 1
R01$4,387,202 · 2
R21$1,094,509 · 2
K01$669,600 · 1
R56$300,000 · 1

Top collaborators

Most similar at Brigham And Women'S Hospital

Same institution · by research overlap

Others in their field

Top investigators on “Cells

Research focus

CellsGenesVariantGeneticPhenotypeCrispr/Cas TechnologyGene ExpressionScreeningGenomeClustered Regularly Interspaced Short Palindromic RepeatsChromatinCrispr ScreenMeasurementLdl Cholesterol LipoproteinsPredictive ModelingCell LineHuman GeneticsTechnologyGenome EditingBaseGenomicsHigh Throughput ScreeningProgramsComputer Analysis

Grant awards (24)

Comprehensive characterization of variants underlying heart and blood diseases with CRISPR base editing$1,890,246
UM1 · FY2025 · HG
High-throughput investigation of human genetic variants affecting cholesterol uptake and efflux$783,155
R01 · FY2025 · HL · contact PI
Comprehensive characterization of variants underlying heart and blood diseases with CRISPR base editing$1,890,246
UM1 · FY2024 · HG
High-throughput investigation of human genetic variants affecting cholesterol uptake and efflux$767,492
R01 · FY2024 · HL · contact PI
Development of potent and predictable Cas9 gene activation tools through high-throughput screening$413,490
R01 · FY2024 · GM · contact PI
Development of potent and predictable Cas9 gene activation tools through high-throughput screening$10,025
R01 · FY2024 · GM · contact PI
Comprehensive characterization of variants underlying heart and blood diseases with CRISPR base editing$1,928,820
UM1 · FY2023 · HG
High-throughput investigation of human genetic variants affecting cholesterol uptake and efflux$783,155
R01 · FY2023 · HL · contact PI
Development of potent and predictable Cas9 gene activation tools through high-throughput screening$413,490
R01 · FY2023 · GM · contact PI
Integrative computational-experimental approaches to stratify monogenic disease risk$300,000
R56 · FY2023 · HG
Comprehensive characterization of variants underlying heart and blood diseases with CRISPR base editing$1,928,820
UM1 · FY2022 · HG
High-throughput investigation of human genetic variants affecting cholesterol uptake and efflux$802,905
R01 · FY2022 · HL · contact PI
Development of potent and predictable Cas9 gene activation tools through high-throughput screening$413,490
R01 · FY2022 · GM · contact PI
Comprehensive characterization of variants underlying heart and blood diseases with CRISPR base editing$1,033,149
UM1 · FY2021 · HG
Correcting genetic disorders using predictable CRISPR/Cas9-induced exon skipping$223,750
R21 · FY2020 · HG · contact PI
Systematic unlocking of airway stem cell differentiation program$200,660
R21 · FY2020 · OD · contact PI
Urgent Supplement: Correcting genetic disorders using predictable CRISPR/Cas9-induced exon skipping$139,773
R21 · FY2020 · HG · contact PI
Correcting genetic disorders using predictable CRISPR/Cas9-induced exon skipping$268,500
R21 · FY2019 · HG · contact PI
Systematic unlocking of airway stem cell differentiation program$261,826
R21 · FY2019 · OD · contact PI
Predictive transcription factor modeling to program endodermal cell fates$133,920
K01 · FY2018 · DK · contact PI
Predictive transcription factor modeling to program endodermal cell fates$133,920
K01 · FY2017 · DK · contact PI
Predictive transcription factor modeling to program endodermal cell fates$133,920
K01 · FY2016 · DK · contact PI
Predictive transcription factor modeling to program endodermal cell fates$133,920
K01 · FY2015 · DK · contact PI
Predictive transcription factor modeling to program endodermal cell fates$133,920
K01 · FY2014 · DK · contact PI